Strömberg Ulf, Bonander Carl, Garmo Hans, Lambe Mats, Stattin Pär, Bratt Ola
School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden.
Regional Cancer Centre Mid-Sweden, Uppsala University Hospital, Uppsala, Sweden; Department of Surgical Sciences, Uppsala University, Uppsala, Swed.
Acta Oncol. 2025 May 15;64:677-684. doi: 10.2340/1651-226X.2025.43399.
Inequity in prostate cancer detection can be assessed by relating the diagnostic intensity to the incidence rate of advanced disease in different population groups, according to factors such as socioeconomic status or ethnicity.
We used nationwide Swedish register data from Prostate Cancer data Base Sweden 5.0 and Statistics Sweden, which enabled us to estimate incidence rates of low-risk prostate cancer (a proxy for diagnostic activity) and advanced disease (locally advanced and/or metastatic) across population groups according to household income, country of birth, and neighborhood-level characteristics.
We found a gradient in the age-standardized incidence of low-risk prostate cancer across income groups, from 60 per 100,000/year in men with high to 34 per 100,000/year in men with low household income: adjusted incidence rate ratio (IRR) 0.65 (95% confidence interval [CI] 0.59-0.71). The gradient in the incidence of advanced disease had the opposite direction, from 44 to 60 per 100,000/year, IRR 1.43 (95% CI 1.31-1.56). Immigrants from a non-Nordic country (nearly 40% from Asia) had lower incidence rates of both low-risk (IRR 0.47, 95% CI 0.42-0.53) and advanced disease (IRR 0.65, 95% CI 0.58-0.73) than men born in a Nordic country. Neighborhood-level analysis considering economic standard, share of immigrants, and degree of urbanization did not clearly differentiate the incidence of advanced disease.
Our results suggest that measures to facilitate early detection of prostate cancer should be targeted to men with a low income. A low diagnostic activity for prostate cancer among immigrants from countries with low background risk may not imply unjustified social disparity.
前列腺癌检测的不平等可以通过将诊断强度与不同人群组中晚期疾病的发病率相关联来评估,评估依据包括社会经济地位或种族等因素。
我们使用了来自瑞典前列腺癌数据库5.0和瑞典统计局的全国性登记数据,这使我们能够根据家庭收入、出生国家和社区层面特征,估计不同人群组中低风险前列腺癌(诊断活动的一个指标)和晚期疾病(局部晚期和/或转移性)的发病率。
我们发现,不同收入组中低风险前列腺癌的年龄标准化发病率存在梯度差异,高收入男性为每10万/年60例,低收入家庭男性为每10万/年34例:调整后的发病率比值(IRR)为0.65(95%置信区间[CI] 0.59 - 0.71)。晚期疾病发病率的梯度方向相反,从每10万/年44例到60例,IRR为1.43(95% CI 1.31 - 1.56)。来自非北欧国家的移民(近40%来自亚洲),其低风险(IRR 0.47,95% CI 0.42 - 0.53)和晚期疾病(IRR 0.65,95% CI 0.58 - 0.73)的发病率均低于出生在北欧国家的男性。考虑经济标准、移民比例和城市化程度的社区层面分析,并未明确区分晚期疾病的发病率。
我们的结果表明,促进前列腺癌早期检测的措施应针对低收入男性。背景风险较低国家的移民中前列腺癌诊断活动较低,这可能并不意味着存在不合理的社会差异。